Corpus ID: 13273906

[Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].

  title={[Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].},
  author={J. Rouffy and J. Loeper},
  volume={27 3},
12 Citations

Topics from this paper

Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile
Both drugs show a greater effect on lowering serum lipid levels in female animals when compared to males, whereas elimination of biliary cholesterol and modifications of bile acids were greater in male animals than female animals. Expand
New drugs affecting lipid metabolism
The search for an ideal hypolipidemic agent still is underway. A relatively large number of the newer hypolipemic agents are related to ethyl p-chlorophenoxyisobutyrate—among them are compounds withExpand
Mechanisms of action of absorbable hypolipidemic drugs.
  • C. Sirtori
  • Medicine
  • Advances in experimental medicine and biology
  • 1985
Current hypotheses on the mode of action of absorbable hypolipidemic agents will be analyzed in detail and specific problems pertaining to their use will be discussed; among these peroxisomal proliferation, reporting new findings suggestive of specific structural features most and least likely to induce this effect. Expand
Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.
Changes in plasma lipoprotein levels and platelet reactivity were evaluated during sequential treatments with clofibrate and tiadenol, two hypolipidemic agents with apparently different mechanisms,Expand
Plasma Lipoprotein Changes Induced by Diets and Drugs
Diet and/or drugs are commonly used for the management of hyperlipoproteinemias (1). On the other hand diets and, at times, drugs are also prescribed to normolipidemic individuals, in the hope ofExpand
Pharmacological studies on tiadenol in type IV patients. Evidence for a mechanism of action different from other lipid-lowering drugs.
Tiadenol administration was remarkably effective in inhibiting fructose induced hypertriglyceridemia in diet responsive type IV patients; it was ineffective in patients with stable, diet refractory, hypertrigenidemia. Expand
Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
Cholesterol synthesis in liver slices was inhibited but hepatic cholesterol 7α hydroxylase was unaffected and liver cholesterol levels were reduced by the higher concentrations of tiadenol. Expand
780 SE: a new type of hypolipemic agent. Comparative assays in rats.
Only 780 SE induced a decrease in blood sugar level, a reduction of plasma insulin concentration and restored the insulin sensitivity to a normal value in obese animals, whereas clofibrate and tiadenol cause hepatomegaly. Expand
Drugs and atherosclerosis.
  • D. Kritchevsky
  • Chemistry, Medicine
  • Verhandlungen der Deutschen Gesellschaft fur Innere Medizin
  • 1975
There are a number of ways in which it is theoretically possible to interfere with lipidemia, including inhibition of cholesterol synthesis, increase of cholesterol catabolism, decreased absorption of lipid, and interference with lipoprotein synthesis or release. Expand